Peringatan Keamanan

Acute Exposure

Nausea, vomiting, diarrhea and abdominal cramping may occur FDA label. Acute exposure to barium sulfate may irritate the eyes and respiratory tract. Exposure to inhalation or other forms can affect the nervous system and lead to hypokalemia, which can contribute to cardiovascular rhythm abnormality L1957. Hypersensitivity, gastrointestinal transit delay, obstruction, aspiration pneumonitis and systemic embolization of barium sulfate are more serious complications of administration FDA label. In addition, fatalities have occurred due to aspiration pneumonitis, barium sulfate impaction, intestinal perforation with subsequent peritonitis and granuloma formation, and vasovagal and syncopal episodes FDA label, A32329.

Chronic Exposure

The lungs may be affected by repeated or prolonged exposure to dust particles, resulting in baritosis (a type of benign pneumoconiosis) L1957. Inhalation of barium sulfate dust may lead to a benign pneumoconiosis ("baritosis") with conspicuous radiographic characteristics but no signs of impairment of pulmonary function L1957.

Intra-abdominal leakage

Intra-abdominal leakage may occur during or after administration of barium sulfate [FDA label}. Caution is advised in several patient conditions such as fistulas, ulcer, inflammatory bowel disease, appendicitis/diverticulitis, severe stenosis or obstruction of the GI tract. Patients should maintain adequate hydration for several days following a barium sulfate procedure to prevent obstruction or impaction caused by batholiths (barium sulfate stones) L1959. Caution is advised in patients with a history of food aspiration and in patients with diagnosed swallowing disorders FDA label.

A note on GI perforation

Perforation of the colon after rectal administration of barium sulfate suspension has been reported due to the increased hydrostatic pressure of the instilled suspension, trauma to the colon from an enema tip, or forceful or deep insertion of a non-flexible enema tip. Perforation of the bowel has been followed by peritonitis, adhesions, granulomas, and death L1958. This is a rare occurrence. Injury to the rectal mucosa or anal canal due to the enema tip or retention balloon is likely the most common traumatic cause of perforation during treatment. Inflation of a balloon within a stricture, neoplasm, inflamed rectum, or stoma is hazardous, and caution should be exerted A32328.

Carcinogenicity and mutagenicity

No animal studies have been performed to evaluate the carcinogenicity of barium sulfate or potential effects on reproduction FDA label. Elective contrast radiography of the abdomen is not routintely recommended during pregnancy because of the risks to the fetus from radiation exposure L1958.

Barium sulfate

DB11150

small molecule approved

Deskripsi

Barium sulfate is an inorganic compound with the chemical formula BaSO4 L1957.

Barium sulfate occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield L1957.

This drug is used as a contrast agent in diagnostic x-ray procedures. Therapeutic advantages of barium sulfate in diagnostic procedures include both its low water solubility and high level of clearance from the body FDA label.

Barium sulfate is ingested by mouth or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced gastrointestinal tract visualization L1957, L1959.

Struktur Molekul 2D

Berat 233.39
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) The rate of excretion of barium sulfate is dependent on the route of administration and the status of peristaltic activity and motility of the gastrointestinal tract [L1959].

Absorpsi

Barium sulfate is not absorbed following oral or rectal administration with a normal gastrointestinal tract. In patients with a normal GI tract, barium sulfate is normally excreted within 24 hr after oral ingestion. Post rectal administration of barium sulfate suspensions, the drug is generally excreted when the enema is released. Some barium may remain in the colon for several weeks, however, and eventually clears, especially in patients with impaired intestinal peristalsis L1957. It is difficult to quantify the uptake of ingested barium because of a number of factors affect its absorption. The presence of sulfate in food can cause the precipitation of barium sulfate L1957. The following is the approximate time to peak opacification of organs by barium sulfate in a healthy GI tract: Esophagus, stomach, and duodenum uptake of barium sulfate occurs almost immediately after oral administration L1958. Small intestine uptake is dependent on gastric emptying rate and viscosity of the preparation; it may be delayed 15-90 minutes post ingestion L1958. Small intestine (enteroclysis studies) uptake is immediate, following direct instillation L1958. Colon and distal small intestine uptake are dependent on patient positioning. Hydrostatic pressure also determines the rate and degree of opacification L1958.

Metabolisme

Barium sulfate is poorly water soluble and shows negligible levels of absorption from the gastrointestinal tract following both oral or rectal administration. In healthy subjects, orally administered barium sulfate is generally excreted within 24 hours. Rectally administered barium sulfate is eliminated with clearance of the enema L1959.

Rute Eliminasi

Barium sulfate is excreted unchanged in the feces L1957.

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Artikel (PubMed)

Contoh Produk & Brand

Produk: 97 • International brands: 0
Produk
  • Anatrast
    Paste • 560 mg/1g • Rectal • US
  • Anatrast Pst 55%
    Paste • 55 % • Rectal • Canada • Approved
  • Baricon
    For suspension • .98 g/1g • Oral • US
  • Baricon for Suspension
    Powder, for suspension • 98 % • Oral • Canada • Approved
  • Baro Bag Enema 98%
    Enema • 98 % • Rectal • Canada • Approved
  • Baro-cat
    Suspension • 15 mg/1mL • Oral; Rectal • US
  • Barobag Enema Kit
    Powder, for suspension • .97 g/1g • Rectal • US
  • Barobag Enema Kit
    Powder, for suspension • .97 g/1g • Rectal • US
Menampilkan 8 dari 97 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul